PPARGC1A and neoplasm: PGC-1α overexpression resulted in an approximate 100-fold increase in PGC-1α mRNA levels in PARCB prostate organoids (SI Appendix, Fig. S12A) and a threefold higher tumor take rate compared with controls (Fig. 6B).